Literature DB >> 1495166

Assessment of left ventricular function using a conductance catheter in the human heart.

M Takeuchi1, H Takaoka, M Odake, Y Hayashi, K Hata, M Yokoyama.   

Abstract

To validate the usefulness of the conductance catheter in the clinical setting, we first studied the accuracy of human left ventricular (LV) volume measured by conductance catheter in comparison with LV volume measured by biplane angiography in 19 patients with heart disease. Secondly, we made a comparison of end-systolic pressure volume relation (ESPVR) and preload recruitable stroke work (PRSW) relation in 60 patients with heart disease. Thirdly, we studied the myocardial oxygen consumption (VO2)-pressure volume area (PVA) relation to assess contractile efficiency in 22 patients with heart disease. There was a good correlation between the corrected conductance volume (Vcc) and the angiographic volume (V angio) (Vcc = 0.94 Vangio + 5.4, r = 0.94, P less than 0.001). Two relations, ESPVR and PRSW, were well described by straight lines with high correlation coefficients. However, PRSW was a more linear contractile index than ESPVR. The reciprocal of the slope of the VO2-PVA relation was approximately 40% in the control contractile state. We conclude that the conductance catheter accurately measures LV volumes and facilitates the assessment of ESPVR, PRSW and contractile efficiency in human LV.

Entities:  

Mesh:

Year:  1992        PMID: 1495166     DOI: 10.1253/jcj.56.730

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  2 in total

1.  Cardiac function evaluated by transesophageal echocardiography during cardiopulmonary bypass.

Authors:  H Kubota; A Furuse; Y Kotsuka; M Ninomiya; K Miyaji; M Endo; S Takamoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-05

2.  Systematic evaluation of different approaches for minimizing hemodynamic changes during pneumoperitoneum.

Authors:  T Junghans; D Modersohn; F Dörner; J Neudecker; O Haase; W Schwenk
Journal:  Surg Endosc       Date:  2006-01-25       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.